Denali Therapeutics
DNLI
#4216
Rank
NZ$4.63 B
Marketcap
NZ$29.66
Share price
0.06%
Change (1 day)
-15.76%
Change (1 year)

Market capitalization of Denali Therapeutics (DNLI)

Market cap: NZ$4.63 Billion

As of January 2026 Denali Therapeutics has a market cap of NZ$4.63 Billion. This makes Denali Therapeutics the world's 4216th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Denali Therapeutics from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$4.63 B1.81%
2025NZ$4.54 B-13.51%
2024NZ$5.25 B12.15%
2023NZ$4.68 B-21.17%
2022NZ$5.94 B-25.4%
2021NZ$7.97 B-42.72%
2020NZ$13.92 B459.51%
2019NZ$2.48 B-14.67%
2018NZ$2.91 B50.49%
2017NZ$1.93 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Denali Therapeutics was reported to be:

NZ$4.61 Billion
by Nasdaq info icon info icon
NZ$4.63 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novocure
NVCR
NZ$2.79 B-39.75% Jersey
Novavax
NVAX
NZ$2.05 B-55.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
NZ$6.37 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
NZ$0.65 B-85.75%๐Ÿ‡ฌ๐Ÿ‡ง UK